Published in Arch Ophthalmol on February 01, 2000
Noninvasive imaging of the human rod photoreceptor mosaic using a confocal adaptive optics scanning ophthalmoscope. Biomed Opt Express (2011) 3.21
Detection of optic nerve head neural canal opening within histomorphometric and spectral domain optical coherence tomography data sets. Invest Ophthalmol Vis Sci (2008) 2.06
A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Exp Eye Res (2010) 1.85
Premise and prediction-how optic nerve head biomechanics underlies the susceptibility and clinical behavior of the aged optic nerve head. J Glaucoma (2008) 1.70
Changes in cellular structures revealed by ultra-high resolution retinal imaging in optic neuropathies. Invest Ophthalmol Vis Sci (2008) 1.51
Deformation of the normal monkey optic nerve head connective tissue after acute IOP elevation within 3-D histomorphometric reconstructions. Invest Ophthalmol Vis Sci (2009) 1.45
The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest Ophthalmol Vis Sci (2005) 1.40
Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog Retin Eye Res (2012) 1.40
IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma. J Neuroinflammation (2012) 1.30
Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers. J Neuroinflammation (2014) 1.26
Outer retinal abnormalities associated with inner retinal pathology in nonglaucomatous and glaucomatous optic neuropathies. Eye (Lond) (2011) 1.24
Glaucoma alters the circadian timing system. PLoS One (2008) 1.17
Functional and morphological effects of laser-induced ocular hypertension in retinas of adult albino Swiss mice. Mol Vis (2009) 1.15
Evidence of outer retinal changes in glaucoma patients as revealed by ultrahigh-resolution in vivo retinal imaging. Br J Ophthalmol (2010) 1.13
Adaptive optics retinal imaging--clinical opportunities and challenges. Curr Eye Res (2013) 1.12
Tracking longitudinal retinal changes in experimental ocular hypertension using the cSLO and spectral domain-OCT. Invest Ophthalmol Vis Sci (2010) 1.04
Effect of experimental glaucoma in primates on oscillatory potentials of the slow-sequence mfERG. Invest Ophthalmol Vis Sci (2006) 1.01
Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA/2J mice. Invest Ophthalmol Vis Sci (2009) 1.00
Physiologic significance of steady-state pattern electroretinogram losses in glaucoma: clues from simulation of abnormalities in normal subjects. J Glaucoma (2009) 0.99
Genetic modification of glaucoma associated phenotypes between AKXD-28/Ty and DBA/2J mice. BMC Genet (2001) 0.98
Neuroglobin in normal retina and retina from eyes with advanced glaucoma. Br J Ophthalmol (2006) 0.95
Acquired color vision loss and a possible mechanism of ganglion cell death in glaucoma. Trans Am Ophthalmol Soc (2000) 0.90
Mechanisms of secondary degeneration after partial optic nerve transection. Neural Regen Res (2014) 0.89
Electroretinography in glaucoma diagnosis. Curr Opin Ophthalmol (2016) 0.88
Microcystic Inner Nuclear Layer Changes and Retinal Nerve Fiber Layer Defects in Eyes with Glaucoma. PLoS One (2015) 0.87
The bugeye mutant zebrafish exhibits visual deficits that arise with the onset of an enlarged eye phenotype. Invest Ophthalmol Vis Sci (2011) 0.85
The non-human primate experimental glaucoma model. Exp Eye Res (2015) 0.84
Improved retinal function after trabeculectomy in glaucoma patients. Graefes Arch Clin Exp Ophthalmol (2009) 0.84
Neuroinflammation in advanced canine glaucoma. Mol Vis (2010) 0.84
Foveal cone photoreceptor involvement in primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol (2010) 0.84
Serial multifocal electroretinograms during long-term elevation and reduction of intraocular pressure in non-human primates. Doc Ophthalmol (2010) 0.83
Oxygen saturation measurements of the retinal vasculature in treated asymmetrical primary open-angle glaucoma using hyperspectral imaging. Eye (Lond) (2014) 0.83
Vitreal oxygenation in retinal ischemia reperfusion. Invest Ophthalmol Vis Sci (2011) 0.83
Cerebral blood flow in glaucoma patients. J Glaucoma (2013) 0.83
Measurement of photoreceptor layer in glaucoma: a spectral-domain optical coherence tomography study. J Ophthalmol (2011) 0.82
Multifocal, pattern and full field electroretinograms in cats with unilateral optic nerve section. Doc Ophthalmol (2000) 0.82
A Review of Adaptive Optics Optical Coherence Tomography: Technical Advances, Scientific Applications, and the Future. Invest Ophthalmol Vis Sci (2016) 0.81
Stem cell therapy for glaucoma: possibilities and practicalities. Expert Rev Ophthalmol (2011) 0.81
E50K-OPTN-induced retinal cell death involves the Rab GTPase-activating protein, TBC1D17 mediated block in autophagy. PLoS One (2014) 0.80
Selective citation of evidence regarding photoreceptor loss in glaucoma. Arch Ophthalmol (2001) 0.80
The morphological difference between glaucoma and other optic neuropathies. J Neuroophthalmol (2015) 0.80
Tools and resources for analyzing gene expression changes in glaucomatous neurodegeneration. Exp Eye Res (2015) 0.79
Regional choroidal blood flow and multifocal electroretinography in experimental glaucoma in rhesus macaques. Invest Ophthalmol Vis Sci (2014) 0.77
The connective tissue phenotype of glaucomatous cupping in the monkey eye - Clinical and research implications. Prog Retin Eye Res (2017) 0.76
Structural and functional effects of hemiretinal endodiathermy axotomy in cynomolgus macaques. Invest Ophthalmol Vis Sci (2013) 0.76
Ultra-high resolution profiles of macular intra-retinal layer thicknesses and associations with visual field defects in primary open angle glaucoma. Sci Rep (2017) 0.75
Relationship between Daytime Sleepiness and Intrinsically Photosensitive Retinal Ganglion Cells in Glaucomatous Disease. J Ophthalmol (2016) 0.75
The pro-inflammatory role of high-mobility group box 1 protein (HMGB-1) in photoreceptors and retinal explants exposed to elevated pressure. Lab Invest (2016) 0.75
Quadrant Field Pupillometry Detects Melanopsin Dysfunction in Glaucoma Suspects and Early Glaucoma. Sci Rep (2016) 0.75
Subfoveal choroidal thickness and glaucoma. The Beijing Eye Study 2011. PLoS One (2014) 0.75
Adaptive optics optical coherence tomography in glaucoma. Prog Retin Eye Res (2016) 0.75
Macular Structure and Function in Nonhuman Primate Experimental Glaucoma. Invest Ophthalmol Vis Sci (2016) 0.75
Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension. Front Neurosci (2017) 0.75
Gene Expression Profiling of the Optic Nerve Head of Patients with Primary Open-Angle Glaucoma. J Ophthalmol (2017) 0.75
An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol (1995) 10.05
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1984) 9.28
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol (1984) 7.68
The Wisconsin age-related maculopathy grading system. Ophthalmology (1991) 7.62
Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology (1999) 6.07
The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology (1984) 5.91
Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol (1976) 5.73
Standard for pattern electroretinography. International Society for Clinical Electrophysiology of Vision. Doc Ophthalmol (2000) 4.70
Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) (1988) 4.47
Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA (1988) 4.31
ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol (2009) 4.22
Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci (1995) 3.78
ISCEV standard for clinical pattern electroretinography--2007 update. Doc Ophthalmol (2007) 3.42
An alternative method of grading diabetic retinopathy. Ophthalmology (1986) 3.05
Visual evoked potentials standard (2004). Doc Ophthalmol (2004) 2.75
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1989) 2.59
The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology (1989) 2.51
New vessel formation beneath the retinal pigment epithelium in senile eyes. Br J Ophthalmol (1973) 2.43
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol (1989) 2.31
Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial. Arch Ophthalmol (1994) 2.15
Council Lecture. Drusen and their relationship to senile macular degeneration. Aust J Ophthalmol (1980) 2.08
Diabetic retinopathy. Assessment of severity and progression. Ophthalmology (1984) 2.05
Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology (1987) 2.00
Cell turnover of capillaries. Lab Invest (1967) 2.00
Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina (1995) 1.88
Macrophages related to Bruch's membrane in age-related macular degeneration. Eye (Lond) (1990) 1.87
Critical period for deprivation amblyopia in children. Trans Ophthalmol Soc U K (1979) 1.84
Morphology of early choroidal neovascularisation in age-related macular degeneration: correlation with activity. Eye (Lond) (1997) 1.80
Natural history of retinal breaks without detachment. Arch Ophthalmol (1974) 1.74
Changes in Thy1 gene expression associated with damaged retinal ganglion cells. Mol Vis (2001) 1.68
Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol (1985) 1.66
Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells. J Natl Cancer Inst (1997) 1.65
Treatment and histopathology of a congenital vitreous cyst. Ophthalmology (1998) 1.64
ISCEV Standard for Clinical Electro-oculography (EOG) 2006. Doc Ophthalmol (2006) 1.60
Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci (1999) 1.60
Evolution of soft drusen in age-related macular degeneration. Eye (Lond) (1994) 1.54
Indocyanine green angiography of drusen. Am J Ophthalmol (1997) 1.47
Widespread choroidal insufficiency in primary open-angle glaucoma. J Glaucoma (1997) 1.46
Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br J Ophthalmol (2009) 1.37
Identity of 4a-carbinolamine dehydratase, a component of the phenylalanine hydroxylation system, and DCoH, a transregulator of homeodomain proteins. Proc Natl Acad Sci U S A (1992) 1.36
An automated statis perimeter/adaptometer using light emitting diodes. Br J Ophthalmol (1983) 1.35
Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol (1965) 1.33
Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol (1999) 1.31
Clinical and experimental evidence that the pattern electroretinogram (PERG) is generated in more proximal retinal layers than the focal electroretinogram (FERG). Ann N Y Acad Sci (1982) 1.31
Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group. N Engl J Med (1997) 1.27
Amblyopia in bilateral infantile and juvenile cataract. Relationship to timing of treatment. Trans Ophthalmol Soc U K (1979) 1.26
Depressive symptoms and quality of life in people with age- related macular degeneration. Ophthalmic Physiol Opt (2011) 1.26
Treatment of diabetic retinopathy. N Engl J Med (1999) 1.25
A forced-choice test improves clinical contrast sensitivity testing. Br J Ophthalmol (1982) 1.25
Clinicopathologic correlations in diabetic retinopathy. II. Clinical and histologic appearances of retinal capillary microaneurysms. Arch Ophthalmol (1977) 1.25
Retinal ischemia in diabetic retinopathy. Arch Ophthalmol (1975) 1.25
Extracts from "clinical evidence": age related macular degeneration. BMJ (2000) 1.22
Bax-dependent and independent pathways of retinal ganglion cell death induced by different damaging stimuli. Exp Eye Res (2000) 1.22
Sub-pigment epithelial membranes after photocoagulation for diabetic macular edema. Arch Ophthalmol (1993) 1.22
Softening of drusen and subretinal neovascularization. Trans Ophthalmol Soc U K (1980) 1.20
Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med (1989) 1.20
Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol (1997) 1.15
Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b. Br J Ophthalmol (1993) 1.15
Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907. J Pharmacol Exp Ther (1995) 1.13
Dowling-Degos disease (reticulate pigmented anomaly of the flexures): a clinical and histopathologic study of 6 cases. J Am Acad Dermatol (1999) 1.12
BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest Ophthalmol Vis Sci (2001) 1.12
Protection of ganglion cells in experimental glaucoma by retinal laser photocoagulation. Arch Ophthalmol (2000) 1.12
Identification of the bcl-2 family of genes in the rat retina. Invest Ophthalmol Vis Sci (1997) 1.11
Pattern ERGs are abnormal in many amblyopes. Trans Ophthalmol Soc U K (1980) 1.10
Mutation in the 4a-carbinolamine dehydratase gene leads to mild hyperphenylalaninemia with defective cofactor metabolism. Am J Hum Genet (1993) 1.10
Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist. J Pharmacol Exp Ther (1999) 1.09
Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis. Arthritis Rheum (2000) 1.07
Electroretinograms evoked in man by local uniform or patterned stimulation. J Physiol (1983) 1.07
Retinoblastoma. Cell of origin. Arch Ophthalmol (1995) 1.06
Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci (1986) 1.05
Spontaneous electrical potentials and pituitary hormone (MSH) secretion. Nature (1976) 1.04
Two-dimensional echocardiographic features of submitral left ventricular aneurysm. Am Heart J (1982) 1.03
Isoniazid pharmacokinetics in kwashiorkor. S Afr Med J (1979) 1.02
Assessment of structure and function over a 3-year period after gene transfer in RPE65-/- dogs. Doc Ophthalmol (2006) 1.00
Is cigarette smoking associated with diabetic retinopathy? Am J Epidemiol (1983) 0.99
An ocular renin-angiotensin system. Immunohistochemistry of angiotensinogen. Invest Ophthalmol Vis Sci (1992) 0.99
Macular edema in Diabetic Retinopathy Study patients. Diabetic Retinopathy Study Report Number 12. Ophthalmology (1987) 0.96
Clinicopathologic correlation of xenon arc and argon laser photocoagulation. Procedure in human diabetic eyes. Arch Ophthalmol (1979) 0.95
Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins. J Virol (1999) 0.95
Selective loss of S-cones in diabetic retinopathy. Arch Ophthalmol (2000) 0.95
Retinopathy in young-onset diabetic patients. Diabetes Care (1985) 0.94
Immunocytochemical features of retinoblastoma in an adult. Arch Ophthalmol (1996) 0.93
Management of oculus fragilis in Ehlers-Danlos type VI. Cornea (2000) 0.93
Selective loss of blue cones and rods in human retinal detachment. Arch Ophthalmol (1995) 0.92
Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers. Cancer Res (2000) 0.92
Adult vitelliform macular degeneration: a clinicopathological study. Eye (Lond) (2003) 0.92
Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor. Am J Clin Nutr (1979) 0.92
Distribution of cathepsin D in human eyes with or without age-related maculopathy. Exp Eye Res (1999) 0.91
Threshold and suprathreshold spatiotemporal response throughout adulthood. J Opt Soc Am A (1988) 0.90
Gene therapy using p21WAF-1/Cip-1 to modulate wound healing after glaucoma trabeculectomy surgery in a primate model of ocular hypertension. Gene Ther (2004) 0.90
A comparison of the electrical properties and morphological characteristics of the smooth muscle of the rat and guinea-pig vas deferens. Pflugers Arch (1977) 0.89
Heat transfer properties, moisture loss, product yield, and soluble proteins in chicken breast patties during air convection cooking. Poult Sci (2001) 0.89
Suppression of first pain and slow temporal summation of second pain in relation to age. J Gerontol A Biol Sci Med Sci (1996) 0.89
Pars intermedia electrical potentials: changes in spike frequency induced by regulatory factors of melanocyte stimulating hormone (MSH) secretion. Neuroendocrinology (1978) 0.89
Isolation of rat cardiac sarcoplasmic reticulum with improved Ca2+ uptake and ryanodine binding. J Mol Cell Cardiol (1991) 0.88
The artifact of retinoscopy revisited: comparison of refractive error measured by retinoscopy and visual evoked potential in the rat. Optom Vis Sci (1997) 0.88